TOX3 Mutations in Breast Cancer

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Jones, James Owain ^a   Chin, Suet Feung ^a,b   Wong Taylor, Li An ^a   Leaford, Donna ^a   Ponder, Bruce A J ^a,b   Caldas, Carlos ^a,b,c   Maia, Ana Teresa ^a,b,d  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Li Ka Shing Centre   (United Kingdom)

^d UNIVERSITY OF ALGARVE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CONTROLLED STUDY; COPY NUMBER VARIATION; EXON; GENE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONSENSE MUTATION; TOX3 GENE;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; LINKAGE DISEQUILIBRIUM; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PROGESTERONE;

EID: 84884378063     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074102     Document Type: Article

References (20)

1. Easton DF, Pooley KA, Dunning AM, Pharoah PDP, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
2. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, et al. (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39: 865-869.
3. Cowper-Sal Lari R, Zhang X, Wright JB, Bailey SD, Cole MD, et al. (2012) Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat Genet 44: 1191-1198.
4. Dittmer S, Kovacs Z, Yuan SH, Siszler G, Kögl M, et al. (2011) TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex. J Cell Sci 124: 252-260.
5. Udler MS, Ahmed S, Healey CS, Meyer K, Struewing J, et al. (2010) Fine Scale mapping of the breast cancer 16q12 locus. Hum Mol Genet.
6. O'Flaherty E, Kaye J, (2003) TOX defines a conserved subfamily of HMG-box proteins. BMC Genomics 4: 13.
7. Yuan SH, Qiu Z, Ghosh A, (2009) TOX3 regulates calcium-dependent transcription in neurons. Proc Natl Acad Sci USA 106: 2909-2914.
8. Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, et al. (2007) High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol 8: R215.
9. Maia AT, Spiteri I, Lee AJ, O'Reilly M, Jones L, et al. (2009) Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast. Breast Cancer Res 11: R88.
10. Ralser M, Querfurth R, Warnatz HJ, Lehrach H, Yaspo ML, et al. (2006) An efficient and economic enhancer mix for PCR. Biochem Biophys Res Commun 347: 747-751.
11. Naderi A, Teschendorff AE, Barbosa-Morais NL, Pinder SE, Green AR, et al. (2007) A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene 26: 1507-1516.
12. Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, et al. (2009) Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37: e67.
13. Bryson K, McGuffin LJ, Marsden RL, Ward JJ, Sodhi JS, et al. (2005) Protein structure prediction servers at University College London. Nucleic Acids Res 33: W36-38.
14. Ng PC, Henikoff S, (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31: 3812-3814.
15. Perou C, Sorlie T, Eisen M, van de Rijn M, Jeffrey S, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
16. Sorlie T, Perou C, Tibshirani R, Aas T, Geisler S, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98: 10869-10874.
17. Boyault S, Drouet Y, Navarro C, Bachelot T, Lasset C, et al. (2012) Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes. Breast Cancer Res Treat 132: 29-39.
18. Gudmundsdottir ET, Barkardottir RB, Arason A, Gunnarsson H, Amundadottir LT, et al. (2012) The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients. BMC Cancer 12: 621.
19. Shan J, Dsouza SP, Bakhru S, Al-Azwani EK, Ascierto ML, et al. (2013) TNRC9 downregulates BRCA1 expression and promotes breast cancer aggressiveness. Cancer Res 73: 2840-2849.
20. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, et al. (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39: D945-950.